Exploratory Phase III Study of Paclitaxel and Cisplatin Versus Paclitaxel and Carboplatin in Advanced Ovarian Cancer
Jan P. Neijt(Leiden University Medical Center), Hans C. van Houwelingen(Leiden University), Malgorzata Tuxen(University of Copenhagen), Peter G. Sørensen(Leiden University Medical Center), Cristiana Sessa(Institute of Oncology Research), Svend Aage Engelholm(Leiden University Medical Center), Mogens Hansen(Leiden University Medical Center), C.A.M. de Swart(Leiden University Medical Center), Birthe Lund(Aalborg University Hospital), Fred R. Hirsch(Tisch Hospital)
Cited by 443
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Lung cancer: current therapies and new targeted treatments
|The Lancet|2016|3.3k
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
|Nature Reviews Clinical Oncology|2021|1.5k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k